Write a review article that describes a controversial topic in pharmacy practice.
Gather legitimate journal articles considering both sides of the issue.
Choose a side of the controversy and use your sources and critical reasoning to support/refute current thought.
Aducanumab, a monoclonal antibody targeting amyloid beta for Alzheimer’s, was granted accelerated approval by the FDA in June 2021, but many still question its efficacy. Was the FDA too quick to approve this drug, or might its benefits outweigh its potential risks? https://www.nature.com/articles/d41586-021-01763-9
1- its a pharmacy doctorate level paper
2- three to five reliable research sources
3- citation with NLM format
Paraphrase and properly cite all sources used using AMA guidelines
Last Completed Projects
| topic title | academic level | Writer | delivered |
|---|